2-(3,4,5-trimethoxyphenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine, 95.0%, 1g

2-[[4-[[4-[Bis-(2-hydroxyethyl)-amino]-phenyl]-(4-chloro-phenyl)-methyl]-phenyl]-(2-hydroxy-ethyl)-amino]-ethanol, 100mg

4-(Morpholine-4-carbonyl)benzaldehyde, 99.0%, 1g

(4-Ethoxy-2,6-dimethylphenyl)boronic acid, 95.0%, 10g

2-(Hydroxymethyl)anthracene-9,10-dione, 1g

(2-Phenyl-imidazo[1,2-a]pyridin-3-yl)-acetic acid, 96%, 100mg

ETHYL 5-HYDROXY-3-OXO-5-PHENYLPENTANOATE, 95.0%, 1g

Dodecylbenzene (hard type) (mixture of branched chain isomers)500mL

9-Oxo-3-azaspiro[5.5]undec-7-ene-8-carbonitrile hydrochloride, 98%, 250mg

2,5-Dihydroxybenzoic acid, 99.0%, 500g

2,3-Diaminobenzoic acid methyl ester, 98.0%, 25g

METHYL N-BOC-MORPHOLINE-3-CARBOXYLATE, 97.0%, 5g

N-Hydroxysuccinimid, min. 99 %, zur Synthese, 500 g, Glasverpackung